PhD Position in Radiopharmaceutical Sciences: Glycoengineered Peptides and Nanobodies for Imaging and Therapy
100%, Zurich, fixed-term
print Drucken
The Center for Radiopharmaceutical Sciences (CRS), a joint research center of ETH Zurich and Paul Scherrer Institute (PSI), is internationally recognized for its pioneering research in radiopharmaceutical chemistry, and targeted radionuclide therapy. The research group of Prof. Roger Schibli ...
Inserat ansehen